Fig. 1From: Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's diseaseDesigned hybrids investigated as selective BuChE inhibitors with anti-Aβ aggregatory, neuroprotective, and metal chelating propertiesBack to article page